Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Australasian Leukaemia And Lymphoma Group

Clinical trials sponsored by Australasian Leukaemia And Lymphoma Group, explained in plain language.

Not yet recruiting 1

Can a targeted drug beat radiation for early-stage lymphoma?

Disease control Not yet recruiting

This phase 3 trial compares the experimental drug surovatamig with standard involved-site radiotherapy (with or without rituximab) in people with limited-stage follicular lymphoma. The goal is to see if surovatamig can produce deeper, longer-lasting responses and reduce the chanc…

Phase 3 • Sponsor: Australasian Leukaemia and Lymphoma Group • Aim: Disease control

Last updated Aug 08, 2026 00:03 UTC